These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 31253120)
1. miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study. Hannafon BN; Cai A; Calloway CL; Xu YF; Zhang R; Fung KM; Ding WQ BMC Cancer; 2019 Jun; 19(1):642. PubMed ID: 31253120 [TBL] [Abstract][Full Text] [Related]
2. Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer. Jin L; Wessely O; Marcusson EG; Ivan C; Calin GA; Alahari SK Cancer Res; 2013 May; 73(9):2884-96. PubMed ID: 23338610 [TBL] [Abstract][Full Text] [Related]
3. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related. Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757 [TBL] [Abstract][Full Text] [Related]
4. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer. Chiyomaru T; Seki N; Inoguchi S; Ishihara T; Mataki H; Matsushita R; Goto Y; Nishikawa R; Tatarano S; Itesako T; Nakagawa M; Enokida H Int J Oncol; 2015 Feb; 46(2):487-96. PubMed ID: 25405368 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression. Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310 [TBL] [Abstract][Full Text] [Related]
6. The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma. Fukumoto I; Koshizuka K; Hanazawa T; Kikkawa N; Matsushita R; Kurozumi A; Kato M; Okato A; Okamoto Y; Seki N Int J Oncol; 2016 Sep; 49(3):1119-29. PubMed ID: 27573718 [TBL] [Abstract][Full Text] [Related]
7. Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma. Ishihara T; Seki N; Inoguchi S; Yoshino H; Tatarano S; Yamada Y; Itesako T; Goto Y; Nishikawa R; Nakagawa M; Enokida H J Urol; 2014 Dec; 192(6):1822-30. PubMed ID: 25014580 [TBL] [Abstract][Full Text] [Related]
8. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells. Ishteiwy RA; Ward TM; Dykxhoorn DM; Burnstein KL PLoS One; 2012; 7(12):e52106. PubMed ID: 23300597 [TBL] [Abstract][Full Text] [Related]
9. The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin. Ell B; Qiu Q; Wei Y; Mercatali L; Ibrahim T; Amadori D; Kang Y J Biol Chem; 2014 Aug; 289(32):21888-95. PubMed ID: 24966325 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356 [TBL] [Abstract][Full Text] [Related]
11. Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer. Eastlack SC; Dong S; Ivan C; Alahari SK Mol Cancer; 2018 Jul; 17(1):100. PubMed ID: 30012170 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line. Pimenta RC; Viana NI; Amaral GQ; Park R; Morais DR; Pontes J; Guimaraes VR; Camargo JA; Leite KR; Nahas WC; Srougi M; Reis ST Tumour Biol; 2018 Nov; 40(11):1010428318803011. PubMed ID: 30400755 [TBL] [Abstract][Full Text] [Related]
13. The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer. Goto Y; Kojima S; Nishikawa R; Enokida H; Chiyomaru T; Kinoshita T; Nakagawa M; Naya Y; Ichikawa T; Seki N Oncotarget; 2014 Sep; 5(17):7748-59. PubMed ID: 25115396 [TBL] [Abstract][Full Text] [Related]
14. Loss of miR-23b/27b/24-1 Cluster Impairs Glucose Tolerance via Glycolysis Pathway in Mice. Jiang YH; Man YY; Liu Y; Yin CJ; Li JL; Shi HC; Zhao H; Zhao SG Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430468 [TBL] [Abstract][Full Text] [Related]
15. The miR-23b/27b/24-1 Cluster Inhibits Hepatic Fibrosis by Inactivating Hepatic Stellate Cells. Wan LY; Peng H; Ni YR; Jiang XP; Wang JJ; Zhang YQ; Ma L; Li R; Han L; Tan Y; Li JM; Cai WL; Yuan WF; Liang JJ; Huang L; Wu X; Zhou Q; Cheng QN; Yang X; Liu MY; Ai WB; Liu CB; Zhang H; Wu JF Cell Mol Gastroenterol Hepatol; 2022; 13(5):1393-1412. PubMed ID: 35093591 [TBL] [Abstract][Full Text] [Related]
16. Promising therapeutic role of miR-27b in tumor. Ding L; Ni J; Yang F; Huang L; Deng H; Wu Y; Ding X; Tang J Tumour Biol; 2017 Mar; 39(3):1010428317691657. PubMed ID: 28351320 [TBL] [Abstract][Full Text] [Related]
17. Novel role of the clustered miR-23b-3p and miR-27b-3p in enhanced expression of fibrosis-associated genes by targeting TGFBR3 in atrial fibroblasts. Yang Z; Xiao Z; Guo H; Fang X; Liang J; Zhu J; Yang J; Li H; Pan R; Yuan S; Dong W; Zheng XL; Wu S; Shan Z J Cell Mol Med; 2019 May; 23(5):3246-3256. PubMed ID: 30729664 [TBL] [Abstract][Full Text] [Related]
18. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer. Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539 [TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells. Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986 [TBL] [Abstract][Full Text] [Related]
20. ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. Wang Y; Rathinam R; Walch A; Alahari SK J Biol Chem; 2009 Aug; 284(34):23094-106. PubMed ID: 19546220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]